|View printer-friendly version|
ASLAN Pharmaceuticals to Participate in Fireside Chat at Jefferies Global Healthcare Conference
MENLO PARK, Calif. and SINGAPORE, May 31, 2022 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq:ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced that Dr Carl Firth, CEO, will participate in a fireside chat at the Jefferies Global Healthcare Conference. The conference will be held in-person in New York, NY, June 8 - 10, 2022.
Management will be available for virtual one-on-one meetings throughout the conference.
Fireside Chat details
Date: Wednesday, June 8, 2022
A replay of the presentation will be available for 90 days at the link above and in the News & Events section of ASLAN Pharmaceutical’s Investor Relations website.
About ASLAN Pharmaceuticals